Tamtam Try Tamtam free
Resilience Care logo

Resilience Care account plan

Remote patient monitoring innovation

At a glance

Resilience Care is a French remote patient monitoring company in oncology, psychiatry and gastroenterology, used by over 42,000 patients in 220+ facilities.

Resilience Care, founded in 2021 by Céline Lazorthes and Jonathan Benhamou and co-founded with Gustave Roussy, sells remote patient monitoring: a patient app plus a Class IIa medical device platform for healthcare professionals. In October 2023 it became the first remote monitoring medical device in oncology reimbursed by French social security; hospitals and cancer centers prescribe it and patients are reimbursed. By September 2026 it covered oncology, psychiatry and gastroenterology, used in routine care by over 42,000 patients across more than 220 healthcare facilities in France, Belgium and Germany, and entered the United States in March 2026. It is venture-backed (a €40M Series A in 2022 and $25M in May 2024 led by Picus Capital and Red River West) and had 150 employees in May 2024; no revenue is disclosed.

Business units

Strategic priorities

European expansion, with Germany first
Resilience Care acquired Germany-based Recovery Cat on 24 September 2026 to "accelerate its footprint in Germany"; Recovery Cat's centers will gradually transition to Resilience Care's platform.
U.S. market entry in oncology
Formal U.S. expansion was announced from Boston on 31 March 2026, with a U.S. leadership team hired from digital health and pharma.
Multi-pathology remote monitoring
The long-term goal is "to become the European leader in remote follow-up care for patients with chronic diseases", reusing one medical and sales organisation across conditions.
Reimbursement in each country
After French reimbursement in October 2023, Resilience filed with the Belgian agency INAMI in January 2024 and negotiated with BfArM in Germany; in Germany it now has a selective care contract with Germany's largest statutory health insurer.
Clinical evidence and pharma trials
The company runs clinical studies and wants to accelerate clinical trials and collaborations with laboratories.

Investments and deals

Recovery Cat acquisition
Announced 24 September 2026: a Charité spin-out co-founded in 2020 by Dr. Jakob Kaminski, with a therapy-monitoring platform for severe psychiatric disorders; no price was disclosed.
GutyCare acquisition
November 2023 purchase of a French gastroenterology and IBS monitoring platform.
$25M funding round
Raised in May 2024, led by Picus Capital and Red River West with Cathay Innovation, Singular and Seaya Ventures, after a €40M Series A in January 2022.
U.S. team
The March 2026 U.S. launch added Greg Orr as General Manager, Eddie Martucci as President, U.S., and industry and nursing advisors.

Challenges and risks

Fragmented reimbursement
Benhamou notes each European country has its specificities; reimbursement must be won country by country, as in Belgium and Germany.
Integrating an acquisition abroad
Recovery Cat's centers must migrate to Resilience Care's platform while keeping their German partnerships and insurer contract.
Proving value in a new U.S. market
In the U.S. the pitch rests on nurse efficiency and new revenue streams for practices rather than on national reimbursement as in France.
Short-staffed hospital customers
Hospitals are often short-staffed, which is both the problem the product addresses and a constraint on deploying it.

What leadership says

“By integrating Recovery Cat, a company with a strong partners network, solid scientific foundations, deep local expertise, and a care contract with Germany's largest insurer, we are strengthening our position as a European player and advancing our ambition to make remote monitoring a standard of care.”

Jonathan Benhamou, co-founder & CEO · Recovery Cat acquisition release, 24 September 2026

“We are helping care teams see risk before it becomes an emergency.”

Greg Orr, General Manager, U.S. · U.S. expansion release, 31 March 2026

“Our goal is to integrate these capabilities into routine care in the US to support both patients and clinicians.”

Charles Ferté, Chief Medical and Patient Experience Officer · U.S. expansion release, 31 March 2026

“This financing will allow us to extend the positive impacts of remote monitoring, therapeutic education, and supportive care to a greater number of patients in France and abroad.”

Céline Lazorthes and Jonathan Benhamou, co-founders and co-CEOs · $25M funding press release, 21 May 2024

Where a supplier can help

Platform integration and migration
Tied to the Recovery Cat integration: data migration, interoperability and hospital IT integration services help move German centers onto Resilience Care's platform.
U.S. go-to-market
Tied to the U.S. market entry: prospecting, sales enablement and market access support fit a new team selling to oncology providers.
Market access and reimbursement
Tied to the fragmented reimbursement challenge: health economics, regulatory and payer-contracting expertise supports country-by-country approvals.
Clinical trial operations
Tied to the pharma trials priority: CRO partnerships and real-world data tooling support the clinical trials RPM platform.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Resilience Care?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Resilience Care

What does Resilience Care do?

It provides remote patient monitoring, a patient app linked to a medical device platform for clinicians, in oncology, psychiatry and gastroenterology, plus monitoring for pharma clinical trials.

Where does Resilience Care operate?

In France, Belgium and Germany, across more than 220 healthcare facilities, and in the United States since its March 2026 oncology launch.

How many employees does Resilience Care have?

The company had 150 employees in May 2024 and planned to recruit 50 to 100 people over the following 18 months.

Who leads Resilience Care?

Co-founders Jonathan Benhamou and Céline Lazorthes; the September 2026 release names Jonathan Benhamou as co-founder & CEO.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)